Board Certified Medical Affairs Specialist Program Accreditation Council for Medical Affairs

About the BCMAS Program


Joanne Lock PharmD, BCMAS

John Smith PhD, BCMAS

Michael Thompson MD, MBA, BCMAS

Why BCMAS?

The Medical Affairs field has grown at a staggering rate of over 300% in the last 10 years and is estimated to continue growing. There are over 7000 drugs in development, many of which are in the rare diseases space. Additionally, health care providers are demanding more in depth, scientific information and education from pharmaceutical companies. This translates into an opportunity for medical affairs to be at the forefront of disseminating scientific & clinical information to physicians and other allied health care professionals.

The BCMAS designation will give you a competitive advantage over other candidates by demonstrating your:

  • Desire and ambition to pursue the highest level of accreditation within medical affairs
  • Motivation to achieve excellence in your field
  • The BCMAS designation is quickly becoming recognized as the gold standard within the pharmaceutical/biotechnology industry as an indication of excellence within medical affairs.

Eligibility Criteria:

To be eligible for the BCMAS program you must:

  • Hold an MD, DO, PhD (life or physical sciences), or PharmD from an accredited institution.

  • Be successfully matriculated in a doctoral level program (MD, DO, PhD, PharmD) within an accredited institution.

  • Foreign Medical Graduates are eligible.

The Credentialing Committee will make the final determination on your eligibility.

Topics Covered

  1. Pharmaceutical Industry Overview
  2. Medical Devices Industry Overview
  3. Diagnostics Overview
  4. Rules governing Interactions with Health Care Providers (HCPs)
  5. Health Economics Outcomes Research (HEOR)
  6. Evidence Based Medicine (EBM)
  7. Clinical Trial Designs
  8. Presentation/Communication Skills
  9. Regulatory Affairs
  10. Overview of Compliance
  11. Abstract/Medical Writing
  12. Publication Practices
  13. Drug Development & Life cycle Management
  14. Overview of Medical Information
  15. Medical Science Liaisons & Field Based Medical Teams
  16. Grant & Investigator Initiated Study (IIS) Funding & Process
  17. Advisory Boards
  18. Phase IV/post-marketing studies overview
  19. REMS
  20. Pharmacovigilance